Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer

被引：1
|
作者：
Niraula, Saroj [1 ]
Tannock, Ian F. [2 ]
机构：
[1] Univ Manitoba, CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada
[2] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 04期
关键词：
D O I：
10.1001/jamaoncol.2015.4682
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：461 / 462
页数：3
相关论文
共 50 条
  • [1] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    C Jin
    Y Fan
    Y Meng
    C Shen
    Y Wang
    S Hu
    C Cui
    T Xu
    W Yu
    J Jin
    [J]. Prostate Cancer and Prostatic Diseases, 2016, 19 : 333 - 339
  • [2] Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer
    Langenhuijsen, Johan F.
    Badhauser, Dirk
    Schaaf, Berthold
    Kiemeney, Lambertus A. L. M.
    Witjes, J. Alfred
    Mulders, Peter F. A.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (05) : 549 - 556
  • [3] Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
    Wolff, Johannes M.
    Abrahamsson, Per-Anders
    Irani, Jacques
    da Silva, Fernando Calais
    [J]. BJU INTERNATIONAL, 2014, 114 (04) : 476 - 483
  • [4] Timing of androgen-deprivation therapy in prostate cancer
    Del Priore, Giuseppe
    Hoffman, Steven
    [J]. LANCET ONCOLOGY, 2017, 18 (11): : E633 - E633
  • [5] METABOLIC SYNDROME IN PATIENTS WITH PROSTATE CANCER UNDERGOING INTERMITTENT ANDROGEN-DEPRIVATION THERAPY
    Rezaei, Mohammadali Mohammadzadeh
    Ghoreifi, Alireza
    Rezaei, Mohammadhadi Mohammadzadeh
    Kerigh, Behzad Feyzzadeh
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E770 - E770
  • [6] Insomnia and androgen-deprivation therapy for prostate cancer
    Savard, J.
    Ivers, H.
    Simard, S.
    [J]. PSYCHO-ONCOLOGY, 2007, 16 (09) : S150 - S151
  • [7] UROLOGICAL CANCER The benefits of intermittent androgen-deprivation therapy
    Mitin, Timur
    Efstathiou, Jason A.
    Shipley, William U.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (12) : 672 - 673
  • [8] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients (vol 19, pg 333, 2016)
    Jin, C.
    Fan, Y.
    Meng, Y.
    Shen, C.
    Wang, Y.
    Hu, S.
    Cui, C.
    Xu, T.
    Yu, W.
    Jin, J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (04) : 429 - 429
  • [9] Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis
    Tsai, Huei-Ting
    Penson, David F.
    Makambi, Kepher H.
    Lynch, John H.
    Van den Eeden, Stephen K.
    Potosky, Arnold L.
    [J]. UROLOGY, 2013, 82 (02) : 327 - 333
  • [10] The benefits of intermittent androgen-deprivation therapy
    Timur Mitin
    Jason A. Efstathiou
    William U. Shipley
    [J]. Nature Reviews Clinical Oncology, 2012, 9 : 672 - 673
12345